or Try an Advanced Search...

    Influenza Vaccine Stocks List

    Symbol Grade Name % Change
    ABT B Abbott Laboratories 0.07
    OPK B OPKO Health Inc. 0.00
    IBIO D iBio, Inc. 3.20
    NVAX F Novavax, Inc. 0.81
    INO F Inovio Pharmaceuticals, Inc. 4.79
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic Medical Devices
    Related Stock Lists: Influenza Infectious Diseases Medicine Cancer Vaccination Vaccines Avian Influenza Biopharmaceutical Coronavirus Pharmaceutical Products Prostate Cancer Seasonal Influenza Thyroid Vascular Products Active Pharmaceutical Ingredients Alzheimer's Disease Angioedema Anthrax Antibiotics Asthma

    Related ETFs - A few ETFs which own one or more of the above listed Influenza Vaccine stocks.

    Symbol Grade Name Weight
    IHI A iShares U.S. Medical Devices ETF 16.82
    PJP D PowerShares Dynamic Pharmaceuticals 5.77
    HART D IQ Healthy Hearts ETF 5.42
    PBE D PowerShares Dynamic Biotech & Genome 4.61
    PCGG B Polen Capital Global Growth ETF 4.56
    View all Influenza Vaccine ETFs...
    Compare ETFs
    Compare HART to PBE Compare IHI to PBE Compare PBE to PCGG

        Influenza Vaccine Stocks Recent News

        Date Stock Title
        Nov 21 ABT Major companies that are also popular short-selling stocks
        Nov 20 NVAX Novavax, Inc. (NVAX) Jefferies London Healthcare Conference (Transcript)
        Nov 20 ABT Is Trending Stock Abbott Laboratories (ABT) a Buy Now?
        Nov 20 OPK OPKO Health to Participate in the Piper Sandler 36th Annual Healthcare Conference
        Nov 18 ABT Inside a $400 billion bet on the brain-computer interface revolution
        Nov 18 OPK NextPlat to Showcase OPKO Healthcare Products at the 2024 China International Natural Health & Nutrition Expo
        Nov 17 ABT First mpox case linked to African outbreak reported in U.S.
        Nov 17 ABT Abbott Laboratories (ABT): A Magnificent Dividend Growth Stock to Buy Now
        Nov 16 INO Inovio Pharmaceuticals Third Quarter 2024 Earnings: US$0.89 loss per share (vs US$1.52 loss in 3Q 2023)
        Nov 16 ABT Plant-Based API Market Poised To Hit $52 Billion By 2034, Driven By Psychedelics And Cannabinoids
        Nov 16 OPK Bitdeer Technologies, PBF Energy, and More Stocks See Action From Activist Investors
        Nov 15 NVAX Update: Moderna, Novavax, Pfizer Shares Fall on Nomination of Anti-Vaxxer as US Health Secretary
        Nov 15 NVAX Powell Speaks The Truth - Market Does Not Like It, Consternation About Kennedy, Gaetz, And Hegseth
        Nov 15 NVAX Vaccine stocks drop on concerns about RFK Jr. heading HHS (update)
        Nov 15 NVAX Trump looks to end EV credit, vaccine stocks fall on RFK JR. pick
        Nov 15 NVAX Pfizer, Moderna, Novavax Take A Beating After Trump Taps Kennedy To Head Up HHS
        Nov 15 NVAX Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4)
        Nov 15 NVAX Trending tickers: Tesla, Alibaba, Pfizer, Domino's and Disney
        Nov 15 NVAX RFK and the 'MAHA Trade': Vaccine makers down, psychedelic shares up
        Nov 15 NVAX Novavax, Inc. (NASDAQ:NVAX) Just Reported Earnings, And Analysts Cut Their Target Price
        Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic Medical Devices
        Related Stock Lists: Influenza Infectious Diseases Medicine Cancer Vaccination Vaccines Avian Influenza Biopharmaceutical Coronavirus Pharmaceutical Products Prostate Cancer Seasonal Influenza Thyroid Vascular Products Active Pharmaceutical Ingredients Alzheimer's Disease Angioedema Anthrax Antibiotics Asthma
        Influenza Vaccine

        The influenza vaccine, also known as the flu shot, is an annual vaccine given to protect against the influenza virus. It is made from inactivated (killed) viruses and is given as an injection into the muscle. The vaccine helps the body develop immunity to the virus, so that if a person is exposed to the virus, their body can fight it off.

        Browse All Tags